107. AI与生命科学的跨界

In this episode of Chengdu Time, Wucheng interviews Brian Hilbisch, author of "In Silico," about the convergence of AI and bioscience and its transformative impact on medicine and drug discovery. They discuss AI's role in improving drug screening efficiency, medical imaging analysis, and gene editing technologies like CRISPR and AlphaFold. Hilbisch shares insights on the potential for AI to accelerate personalized medicine, assist doctors, and revolutionize virtual hospitals, while also addressing challenges such as data privacy and the need for human oversight. The conversation explores the historical context of pharmaceutical development, emphasizing the importance of cross-disciplinary collaboration and the potential for AI to drive innovation in the field, ultimately aiming for healthier aging and more effective cancer treatments.